BetterLife Pharma (BETR.CN) closed a public offering of shares and pre-funded warrants that raised $100 million, it said Thursday.
The company sold 447.0-million shares priced at CA$0.25 apiece and 108.0-million pre-funded warrants at CA$0.24999 apiece.
The biotechnology company plans to use proceeds to conduct clinical trials, studies and for working capital and other general corporate needs.
Shares of the company were last seen up CA$0.02, or 5.6%, to CA$0.38 on the Canadian Securities Exchange.
Price: $0.38, Change: $+0.02, Percent Change: +5.56%